ARTICLE | Clinical News
SynGEM: Ph I started
November 8, 2016 9:16 PM UTC
Mucosis began a double-blind, placebo-controlled, U.K. Phase I trial to evaluate 2 intranasal doses of SynGEM in 48 healthy adult volunteers....
BCIQ Company Profiles
Mucosis began a double-blind, placebo-controlled, U.K. Phase I trial to evaluate 2 intranasal doses of SynGEM in 48 healthy adult volunteers....
BCIQ Company Profiles